Form 8-K - Current report:
SEC Accession No. 0001683168-20-001935
Filing Date
2020-06-11
Accepted
2020-06-11 16:30:11
Documents
2
Period of Report
2020-06-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm 8-K 18542
2 PRESS RELEASE cns_8k-ex9901.htm EX-99.1 12473
  Complete submission text file 0001683168-20-001935.txt   32125
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 20957502
SIC: 2834 Pharmaceutical Preparations